Adept Robotics Selected For Insulet Corporation’s Revolutionary ''OmniPod(TM)’' Diabetes Management System

LIVERMORE, Calif.--(BUSINESS WIRE)--April 25, 2006--Adept Technology, Inc. (NASDAQ:ADEP - News), the leading provider of intelligent vision-guided robotics and global robotics services, announced a major medical device automation program with Insulet Corporation for the OmniPod(TM) Insulet Management System, a disruptive technology for insulin delivery in diabetes management.

MORE ON THIS TOPIC